Skip to main content
Stephen Krieger, MD, Neurology, New York, NY, The Mount Sinai Hospital

StephenCharlesKriegerMD

Neurology New York, NY

Associate Professor, Neurology, Icahn School of Medicine

Dr. Krieger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Krieger's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 2003 - 2006
  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Internal Medicine, 2002 - 2003
  • Yale School of Medicine
    Yale School of MedicineClass of 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 2005 - 2025
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Fellow of the American Academy of Neurology AAN, 2016
  • Healthcare Professional of the Year Award National Multiple Sclerosis Society, Southern New York Chapter, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Homing in on Consciousness in the Nervous System: An Action-Based Synthesis  
    Adam Gazzaley, Stephen C Krieger, The Behavioral and Brain Sciences

Authored Content

  • Maintaining Multiple Sclerosis Care with Virtual VisitsNovember 2020
  • Tips for Conducting a Virtual Neurologic ExamOctober 2020

Press Mentions

  • Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
    Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS CareOctober 26th, 2022
  • Phase 3 Trial of Sativex, Cannabis Extract Treatment for MS Spasticity, Opens in US
    Phase 3 Trial of Sativex, Cannabis Extract Treatment for MS Spasticity, Opens in USNovember 5th, 2020
  • GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated Spasticity
    GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated SpasticityNovember 3rd, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations